Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.76
-0.29 (-1.70%)
Nov 11, 2026, 4:08 PM HKT

Sinopharm Group Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
571,303575,168584,508596,570552,148521,051
Revenue Growth
-0.39%-1.60%-2.02%8.04%5.97%14.16%
Gross Profit
40,28641,67244,25548,51247,43444,051
Operating Income
16,94817,23017,81922,31822,76420,984
Net Income
7,1627,1557,0509,0548,5267,759
Earnings Per Share
2.292.292.262.902.742.49
EPS Growth
0.92%1.37%-22.10%6.02%10.02%7.63%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Retail Pharmacy
38,38335,98135,68932,97929,059
Eliminations
-22,997-22,860-20,769-18,496-15,913
Medical Device Distribution
115,538117,915130,213120,851108,129
Other Business
8,8539,10610,38610,2099,821
Pharmaceutical Distribution
435,392444,365441,051406,604389,955
Total
575,168584,508596,570552,148521,051

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37,83351,55457,48667,13958,42146,353
Total Debt
73,71370,96076,38673,78269,59068,368
Net Cash (Debt)
-35,881-19,407-18,900-6,643-11,169-22,016
Net Cash Growth
------
Net Cash Per Share
-11.49-6.22-6.06-2.13-3.58-7.05

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
29,28114,13811,54617,17320,9649,308
Capital Expenditures
-1,364-1,496-1,471-1,960-2,127-2,074
Free Cash Flow
27,91712,64210,07515,21318,8377,234
Free Cash Flow Growth
47.22%25.49%-33.78%-19.23%160.38%-21.85%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.05%7.25%7.57%8.13%8.59%8.45%
Operating Margin
2.97%3.00%3.05%3.74%4.12%4.03%
Pretax Margin
2.58%2.57%2.40%3.27%3.36%3.26%
Profit Margin
1.25%1.24%1.21%1.52%1.54%1.49%
FCF Margin
4.89%2.20%1.72%2.55%3.41%1.39%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8050.6900.6800.8700.8200.750
Dividend Per Share Growth
6.90%1.47%-21.84%6.10%9.33%8.70%
Dividend Yield
4.80%3.95%3.40%4.69%4.67%5.43%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.267.628.866.406.425.56
Forward PE
6.006.857.015.826.054.93
P/FCF Ratio
1.604.316.203.812.915.96
PS Ratio
0.080.100.110.100.100.08